Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today announced its continued ...
This week, the European Commission granted approval to Merck’s MRK novel HIF-2α inhibitor, Welireg, for two indications. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback